Molecular features of TNBC as compared to the HER2+ and ER+/PR+ breast carcinoma.

* Indicates a significant difference at the 5% level▯Indicate significant differences between TNBC and HER2+ groups❖Indicate significant differences between TNBC, HER2+ and ER+/PR+ groupsMolecular features of TNBC as compared to the HER2+ and ER+/PR+ breast carcinoma.* 表示在5%显著性水平下存在显著差异 ▯ 表示三阴性乳腺癌（Triple-Negative Breast Cancer, TNBC）与人类表皮生长因子受体2阳性（HER2+）组间存在显著统计学差异 ❖ 表示三阴性乳腺癌（TNBC）、人类表皮生长因子受体2阳性（HER2+）与雌激素受体（Estrogen Receptor, ER）/孕激素受体（Progesterone Receptor, PR）阳性（ER+/PR+）组间存在显著统计学差异 三阴性乳腺癌与HER2阳性、ER+/PR+乳腺癌的分子特征对比